Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04993469
Other study ID # B6702021000410
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 27, 2021
Est. completion date December 31, 2030

Study information

Verified date December 2023
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.


Description:

Gender dysphoria refers to an inner mental unrest resulting from an incongruity between the assigned biological sex and the mentally experienced sex. The generally accepted treatment for gender dysphoria aims to bring a person's physical characteristics in line with his or her perceived gender identity. This gender-affirming treatment consists of a combination of psychological counselling, hormonal therapy and, if desired, genital gender-affirming surgery. This involves the removal of the biological reproductive organs and in some cases (part of) the biological sex organs. These can be replaced by surrogate sex organs of the desired sex while maintaining urological and sexual function. In transgender women, this is achieved with vulvoplasty or vaginoplasty, while in transgender men, metoidioplasty or phalloplasty is performed. While urological functioning is an extensively studied topic in transgender patients after genital gender confirmation surgery, sexual functioning is often considered of secondary importance, even though it is one of the goals of gender confirmation surgery. In the transgender man, a phalloplasty is performed using microsurgical techniques that allow the nerves of the donor flap (usually from the forearm or upper leg) to be connected to the genital and inguinal nerves. In metoidioplasty, the clitoris is preserved and forms the base of a micro-penis. In the transgender woman, the glans penis is partially preserved to create a clitoris. The purpose of this is to achieve maximum sensitivity of the genital area. There are few reports in the literature demonstrating sensory recovery in these extensively operated body parts, let alone what the added value on sexual functioning might be as a result of this recovery of genital sensitivity. At Ghent University Hospital, we now have more than 30 years' experience with such operations and have shared this experience in an almost entirely retrospective manner in various publications to date. However, in order to address the bias associated with retrospective research, this study aims to prospectively and observationally collect data on these patients who are counseled in a pathway for gender dysphoria. This study will include all patients - after informed consent - and will collect specific data on surgical outcome (complications after surgery, duration of surgery, type of surgery) and functional outcome (tailored questionnaires for patients undergoing such a treatment with questions on urination, erections, sexual experience, quality of life, patient satisfaction and genital sensitivity) for each of these various surgical options. These outcomes will be verified at follow-up moments (after 3 months, 6 months, 12 months and 24 months). Specifically for the component on genital sensitivity, we plan to follow up patients 3-monthly by means of a Semmes-Weinstein monofilament test of the genital region up to 24 months postoperatively. The aim of this study is therefore to use this prospectively collected data to truthfully map our experience, to be critical, to reflect and optimize our daily clinical practice in the interest of the patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2030
Est. primary completion date December 31, 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years to 110 Years
Eligibility Inclusion Criteria: - Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations - Patient age = 18 years - Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery - Fit for operation, based on the surgeon's expert opinion - Patient is able and willing to attend the follow-up consultations Exclusion Criteria: - Absence of signed written informed consent and thus a patient unwilling to participate. - Patient age < 18 years - Cisgender patients - Patients unfit for operation - Patient declares that it will be impossible for him to attend the follow-up consultations

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Semmes-Weinstein monofilament testing and questionnaires
Semmes-Weinstein test for the assessment of genital sensation Battery of questionnaires assessing sexual function, voiding function, quality of life and patient satisfaction

Locations

Country Name City State
Belgium University Hospital Ghent Ghent East-Flanders

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in genital sensitivity pattern at 24 months Mapping of pressure thresholds of Semmes-Weinstein monofilaments in pre-defined areas of the neo-genital area Baseline function test, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up
Secondary Change in postoperative sexual function Assessed with Male Sexual Health Questionnaire/Female Sexual Function Index questionnaires (MSHQ/FSFI) with added questions specifically on penetrative sexual activity Baseline questionnaire, followed by reassessment at 12 and 24 months of follow-up
Secondary Change in self-assessment of genital anatomy and genital sensitivity Assessed with Self-Assessment of Genital Anatomy and Sexual Function (Male and Female) questionnaires (SAGASF-M/SAGASF-F) Baseline questionnaire, followed by reassessment at 3, 6, 9, 12, 15, 18, 21 and 24 months of follow-up
Secondary Change in voiding function Assessed with International Consultation on Incontinence Questionnaire on Male and Female Lower Urinary Tract Symptoms (ICIQ-MLUTS/ICIQ-FLUTS) Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Change in urinary continence Assessed with International Consultation on Incontinence Questionnaire on Urge Incontinence short form questionnaire (ICIQ-UI SF) Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Change in maximum flow rate Assessed by uroflowmetry (Qmax) Uroflowmetry at baseline, followed by uroflowmetry at 3, 6, 12 and 24 months of follow-up
Secondary Change in satisfaction with life by Likert and VAS scales Assessed with Satisfaction with life scale (SWLS) questionnaire Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Change in satisfaction with life by Likert and VAS scales Assessed with Subjective happiness scale (SHS) questionnaire Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Change in quality of life assessed by Likert scales. Assessed by the EuroQol questionnaire EQ-5D-3L. Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Change in quality of life assessed by VAS scale. Assessed by the EuroQol questionnaire EQ-VAS (0-100) Baseline questionnaire, followed by reassessment at 3, 6, 12 and 24 months of follow-up
Secondary Subjective patient satisfaction with surgical and functional outcome assessed by Likert scales. Assessed with seven subjective patient satisfaction questions on different surgical and functional outcomes aspects using Likert scales Assessed at 12 and 24 months of follow-up
Secondary Patient motivations for surgery and extent to which these expectations were met as a result of the operation assessed by VAS scales Assessed with fourteen motivational questions using VAS scales (0-100) Baseline questions, followed by reassessed at 12 and 24 months of follow-up
Secondary Postoperative complication rate Categorized according to Clavien-Dindo classification system Within 90 days postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT06098781 - Gynaecological Gender-affirming Surgeries
Recruiting NCT04064671 - ZEPHYR: A Study Evaluating Surgical Outcome After Implantation of the Zephyr ZSI 475 FTM Inflatable Penile Implant in the Neophallus After Female-to-male Sex Reassignment Surgery
Completed NCT03602222 - An LGBT-Competency Program for Mental Health Professionals in Romania N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Completed NCT04195659 - Chest Dysphoria in Transmasculine Spectrum Adolescents
Not yet recruiting NCT05903911 - Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria N/A
Not yet recruiting NCT04160364 - Gender Dysphoria in Children and Adolescents : Parents' Perspectives
Not yet recruiting NCT04265885 - Gender Dysphoria and Transition
Recruiting NCT06245681 - Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content
Active, not recruiting NCT05489159 - Sleep and IR in Transgender Adolescents
Recruiting NCT04736797 - Transition in Transgender
Recruiting NCT04979338 - Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries Phase 3
Recruiting NCT05829928 - Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
Recruiting NCT05884307 - Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Completed NCT04290286 - i2TransHealth: Interdisciplinary, Internet-based Trans Health Care N/A
Terminated NCT03078829 - The Relation of GnRH Treatment to QTc Interval in Transgender Females
Recruiting NCT05649605 - Early Mental Response - The EMRE Study N/A
Recruiting NCT05204732 - Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People N/A
Recruiting NCT06291675 - Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content